Predictors of cognitive impairment in an early stage Parkinson's disease cohort
about
Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's diseaseRepurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's diseasePeople with Parkinson's disease and normal MMSE score have a broad range of cognitive performanceTracking Parkinson's: Study Design and Baseline Patient Data.Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease.Design of the Park-in-Shape study: a phase II double blind randomized controlled trial evaluating the effects of exercise on motor and non-motor symptoms in Parkinson's disease.Screening Mild and Major Neurocognitive Disorders in Parkinson's Disease.Association between Community Ambulation Walking Patterns and Cognitive Function in Patients with Parkinson's Disease: Further Insights into Motor-Cognitive Links.Screening for Mild Cognitive Impairment in Parkinson's Disease: Comparison of the Italian Versions of Three Neuropsychological Tests.MMSE and MoCA in Parkinson's disease and dementia with Lewy bodies: a multicenter 1-year follow-up studyVariation in Recent Onset Parkinson's Disease: Implications for Prodromal Detection.Prevalence and Subtypes of Mild Cognitive Impairment in Parkinson's Disease.Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's diseaseThe influence of vascular risk factors on cognitive function in early Parkinson's disease.Antisaccades and executive dysfunction in early drug-naive Parkinson's disease: The discovery study.Sensorineural Organs Dysfunction and Cognitive Decline: A Review Article.Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study.α-synuclein genetic variability: A biomarker for dementia in Parkinson disease.Simple Test of Manual Dexterity Can Help to Identify Persons at High Risk for Neurodegenerative Diseases in the Community.Correlative factors of cognitive dysfunction in PD patients: a cross-sectional study from Southwest China.Vascular Risk Factors and Cognition in Parkinson's Disease.Effect on Gait Speed, Balance, Motor Symptom Rating, and Quality of Life in Those with Stage I Parkinson's Disease Utilizing LSVT BIG®.Context-Dependent Learning in People With Parkinson's Disease.Gait and Cognition in Parkinson's Disease: Cognitive Impairment Is Inadequately Reflected by Gait Performance during Dual Task.Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder.Phenotypic variability of PINK1 expression: 12 Years' clinical follow-up of two Italian families.Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease.Validation of Neuropsychological Tests to Screen for Dementia in Chinese Patients With Parkinson's Disease.Impaired Quality of Life and Need for Palliative Care in a German Cohort of Advanced Parkinson's Disease Patients.Mild Cognitive Impairment in Parkinson's Disease-What Is It?
P2860
Q21131066-19B43028-419C-4487-9614-FF1D47BC8FDAQ26748711-6474371A-72FD-4D1F-8F3D-5FECC0AC05A7Q30586896-B46B3434-A047-4E98-A965-C82D192C3292Q31008758-B9D7967E-01F2-451B-BB32-9844870D89A3Q31097087-9F14F22F-A3DA-4DAF-A0D8-4CB5D4F953EEQ34432509-9B3EB8F2-CB94-4198-8BA6-3A68C45711B8Q35564412-E38695B7-006B-4ED2-9715-37367BCD48BBQ35674661-650D919C-9373-4D82-98F7-21A83F7CDDD5Q36271898-7A99BF72-20A9-44B1-B0F2-910296C09268Q36304622-127F936E-6D33-4510-A259-C8EE1803D5CAQ36763084-53599BAE-BCA2-4101-BDA0-C416908A14CAQ37054007-7DFE88B4-B475-46D4-872A-5A814D221F21Q37271669-87D371B9-A66E-4ED1-9C59-0F39024360C6Q37371113-24C0DCC1-0D7F-4156-A11B-10E3D4BD24E2Q38376727-C209B42C-555B-4CFE-8BA2-66DB1272D5BCQ38417644-84F16BC4-26D8-4052-BA88-DD1E1632770AQ38774726-2A67D146-2C80-4F31-841A-3FF6AF710980Q39170813-59E8887C-0032-4AB3-9217-FB181F13A10FQ39841127-B8449F06-30C4-4C00-BBD4-B566D2CFDD63Q40670425-15B26AE5-355A-41D2-B10B-5922F4921DFEQ40792593-8AF5AA84-9657-49B7-B66D-49A20D1F1BFEQ40902411-B41A50CA-8CD6-4064-AA5D-609E3D42A1AFQ42055538-98E04205-C2F9-4D84-9B18-C261ABDDA0F5Q44487807-98DA65AD-82A7-40AB-AC46-F4DC67A1BECBQ46912801-48EFC961-B9CD-4CD6-8E11-A36B4C930EF6Q47323174-E4716651-8FD8-4013-9575-4BDA7C9A0F82Q48034191-AD82A6DA-618D-482E-87B7-E47B678A4B1DQ50534716-9CB955BD-6299-443D-AA87-F9840B8CE754Q50551156-E32C7A43-CD91-4E3B-B058-303469C486B2Q55176226-B2C1FECB-4C34-4898-8C46-1FA4ED46D4B4Q55387790-310D2278-4A48-47D8-AE73-AF0DAC65807A
P2860
Predictors of cognitive impairment in an early stage Parkinson's disease cohort
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Predictors of cognitive impairment in an early stage Parkinson's disease cohort
@ast
Predictors of cognitive impairment in an early stage Parkinson's disease cohort
@en
Predictors of cognitive impairment in an early stage Parkinson's disease cohort
@nl
type
label
Predictors of cognitive impairment in an early stage Parkinson's disease cohort
@ast
Predictors of cognitive impairment in an early stage Parkinson's disease cohort
@en
Predictors of cognitive impairment in an early stage Parkinson's disease cohort
@nl
prefLabel
Predictors of cognitive impairment in an early stage Parkinson's disease cohort
@ast
Predictors of cognitive impairment in an early stage Parkinson's disease cohort
@en
Predictors of cognitive impairment in an early stage Parkinson's disease cohort
@nl
P2093
P2860
P50
P356
P1433
P1476
Predictors of cognitive impairment in an early stage Parkinson's disease cohort
@en
P2093
Clara Murray
Kannan Nithi
Konrad Szewczyk-Królikowski
Paul Tomlinson
P2860
P304
P356
10.1002/MDS.25748
P407
P577
2014-01-06T00:00:00Z